New patent for Maia Pharms drug ANGIOMAX RTU

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ANGIOMAX+RTU
Annual Drug Patent Expirations for ANGIOMAX+RTU

Angiomax Rtu is a drug marketed by Maia Pharms Inc and is included in one NDA. It is available from three suppliers. There are two patents protecting this drug.

This drug has one patent family member in one country.

The generic ingredient in ANGIOMAX RTU is bivalirudin. Three suppliers are listed for this compound. Additional details are available on the bivalirudin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top